NeuroOne developed OneRF to treat epilepsy and recently took first steps to expand its use to trigeminal neuralgia.

CLEVELAND -- Splanchnic nerve ablation was safe in heart failure with preserved ejection fraction (HFpEF) and showed some signal of benefit in volume management in the REBALANCE-HF feasibility study.

EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...

NeuroOne Medical Technologies has submitted its 510(k) filing to the FDA for a new treatment option for trigeminal neuralgia earlier than anticipated, indicating efficient progress in product ...

Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. "We often see patients with chronic low back pain who ...

This content is sponsored by MedStar Washington Hospital Center. In 2022, the University of Michigan’s National Poll on Healthy Aging found that 70% of older adults experienced joint pain. Nerve pain ...

Please provide your email address to receive an email when new articles are posted on . Splanchnic ablation could improve exercise capacity and pulmonary capillary wedge pressure in some patients with ...

EDEN PRAIRIE, MINN. - March 26, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the ...

Radiofrequency ablation (RFA) represents a rapidly advancing minimally invasive intervention for the management of chronic knee pain, particularly in patients with osteoarthritis and post-surgical ...

EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...